Gut Biomtech Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
5
- Latest Deal Type
-
Early Stage VC
- Investors
-
6
Gut Biomtech General Information
Description
Developer of microbiome-based therapeutic and genomic analysis systems designed for clinical and research purposes. The company's platform integrates living microbiome cultivation with anaerobic strain library development, gut microbiome genome analysis using next generation sequencing, pipelines for probiotic and pharmabiotic candidates targeting inflammatory bowel disease obesity immune function, and establishment of a human microbiome banking system, enabling biomedical researchers and health focused organizations to advance disease correlation studies therapeutic development and microbiome driven diagnostics through controlled cultivation workflows and comprehensive genomic insight.
Contact Information
Website
www.gutbt.comCorporate Office
- Room 407, Building E9, 1 Chungdae-ro, Seowon-gu
- Gaesin-dong, Chungbuk National University Academic-Industrial Joint Technology Research In
- Cheongju, Chungcheongbuk
- South Korea
Corporate Office
- Room 407, Building E9, 1 Chungdae-ro, Seowon-gu
- Gaesin-dong, Chungbuk National University Academic-Industrial Joint Technology Research In
- Cheongju, Chungcheongbuk
- South Korea
Gut Biomtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Early Stage VC | 01-Oct-2026 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | Completed | Stealth | ||||
| 3. Seed Round | 21-Dec-2023 | Completed | Stealth | |||
| 2. Accelerator/Incubator | 30-Sep-2023 | Completed | Stealth | |||
| 1. Seed Round | 10-Nov-2022 | Completed | Stealth |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Gut Biomtech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Gut Biomtech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Gut Biomtech Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nautilus Investment (South Korea) | Venture Capital | Minority | ||
| iAccel (Seongnam-si) | Venture Capital | Minority | ||
| InfoBank | Venture Capital | Minority | ||
| Oracle Venture Investment | Venture Capital | Minority | ||
| Tech Incubator Program for Startup | Accelerator/Incubator | Minority |
Gut Biomtech FAQs
-
When was Gut Biomtech founded?
Gut Biomtech was founded in 2022.
-
Where is Gut Biomtech headquartered?
Gut Biomtech is headquartered in Cheongju, South Korea.
-
What is the size of Gut Biomtech?
Gut Biomtech has 5 total employees.
-
What industry is Gut Biomtech in?
Gut Biomtech’s primary industry is Biotechnology.
-
Is Gut Biomtech a private or public company?
Gut Biomtech is a Private company.
-
What is Gut Biomtech’s current revenue?
The current revenue for Gut Biomtech is .
-
Who are Gut Biomtech’s investors?
Nautilus Investment (South Korea), iAccel (Seongnam-si), InfoBank, Oracle Venture Investment, and Tech Incubator Program for Startup are 5 of 6 investors who have invested in Gut Biomtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
